|
|
Volumn 124, Issue 12, 1996, Pages 1086-1088
|
|
Protease inhibitors for HIV infection
a
a
Ross 1159
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CYTOCHROME P450 INHIBITOR;
DESIGNER DRUG;
DIDANOSINE;
INDINAVIR;
KETOCONAZOLE;
LAMIVUDINE;
NELFINAVIR;
NUCLEOSIDE ANALOG;
PLACEBO;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG FORMULATION;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
ORAL DRUG ADMINISTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
|
|
EID: 0030317629
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-124-12-199606150-00011 Document Type: Editorial |
|
Times cited : (63)
|
|
References (18)
|
